Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Standard BioTools Inc
NASDAQ:LAB
Standard BioTools Inc
NASDAQ:LAB
Price:
0.6224
USD
0.39%
Market Closed
Market Cap:
$245.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Standard BioTools Inc
NASDAQ:LAB
|
US |
|
S
|
Southern Cross Media Group Ltd
F:6MM
|
AU |
|
P
|
PPG Industries Inc
XMUN:PPQ
|
US |
|
P
|
Pakistan State Oil Company Ltd
KAR:PSO
|
PK |
Wall St Price Targets
LAB Price Forecast
Based on 2 analysts
Based on 2 analysts
+121% Upside
from
$0.6224
today
Standard BioTools Inc (LAB)’s 12-month stock price forecast through November 2027 has a consensus target of $1.377, implying 121% upside. The forecast is based on price targets from 2 Wall Street analysts.
LAB Analyst Rating
Based on 1 analyst
Based on 1 analyst
The analyst rating for LAB is Hold.
Standard BioTools Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LAB's stock price target?
Price Target
1.377
USD
1.377
USD
According to Wall Street analysts, the average 1-year price target for LAB is 1.377 USD with a low forecast of 1.3635 USD and a high forecast of 1.4175 USD.
What is the Revenue forecast for Standard BioTools Inc?
Projected CAGR
1%
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 4 years is 1%.
What is the Gross Profit forecast for Standard BioTools Inc?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 4 years is 4%.
